Limits...
Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia.

Wisman PP, Teraa M, de Borst GJ, Verhaar MC, Roest M, Moll FL - PLoS ONE (2015)

Bottom Line: Patients with critical limb ischemia (CLI) have a high risk to develop cardiovascular events (CVE).Maximal reactivity to stimulation of the collagen and thrombin activation pathway was decreased in CLI patients compared to healthy controls.In line, attenuated platelet reactivity to stimulation of multiple activation pathways was associated with several traditional risk factors for cardiovascular disease.

View Article: PubMed Central - PubMed

Affiliation: Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, 3584CX, The Netherlands; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, 3584CX, The Netherlands.

ABSTRACT

Background: Patients with critical limb ischemia (CLI) have a high risk to develop cardiovascular events (CVE). We hypothesized that in CLI patients platelets would display increased baseline activation and reactivity.

Objectives: We investigated baseline platelet activation and platelet reactivity in patients with CLI.

Patients/methods: In this study baseline platelet activation and platelet reactivity in response to stimulation of all major platelet activation pathways were determined in 20 CLI patients (11 using aspirin and 9 using vitamin K-antagonists) included in the Juventas-trial (clinicaltrials.gov NCT00371371) and in 17 healthy controls. Platelet activation was quantified with flow cytometric measurement of platelet P-selectin expression and fibrinogen binding.

Results: CLI patients not using aspirin showed higher baseline platelet activation compared to healthy controls. Maximal reactivity to stimulation of the collagen and thrombin activation pathway was decreased in CLI patients compared to healthy controls. In line, attenuated platelet reactivity to stimulation of multiple activation pathways was associated with several traditional risk factors for cardiovascular disease.

Conclusions: Baseline platelet activation was increased in CLI patients, whereas the reactivity of circulating platelets to several stimulatory agents is decreased. Reactivity of platelets was inversely correlated with cardiovascular risk factors.

No MeSH data available.


Related in: MedlinePlus

Baseline platelet activation of CLI A- patients versus healthy controls and CLI A- patients versus CLI A+ patients.MFI for bound fibrinogen or P-selectin expression without stimulation, stratified for CLI A- patients versus healthy controls and CLI A- patients versus CLI A+ patients. MFI median fluorescence intensity, * p<0.05.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4492682&req=5

pone.0131356.g001: Baseline platelet activation of CLI A- patients versus healthy controls and CLI A- patients versus CLI A+ patients.MFI for bound fibrinogen or P-selectin expression without stimulation, stratified for CLI A- patients versus healthy controls and CLI A- patients versus CLI A+ patients. MFI median fluorescence intensity, * p<0.05.

Mentions: Baseline platelet activation was determined with the P-selectin expression and the fibrinogen binding capacity of the patient-derived platelets without stimulation with an agonist. Baseline platelet αIIBβ3 activation did not differ between CLI A- patients and healthy controls (73.7±12.9 vs. 80.3±9.7, p = 0.682). Baseline P-selectin expression was significantly higher in CLI patients compared to healthy controls (59.4±4.8 vs. 40.3±8.6, p<0.001; Fig 1 and Fig A in S1 file).


Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia.

Wisman PP, Teraa M, de Borst GJ, Verhaar MC, Roest M, Moll FL - PLoS ONE (2015)

Baseline platelet activation of CLI A- patients versus healthy controls and CLI A- patients versus CLI A+ patients.MFI for bound fibrinogen or P-selectin expression without stimulation, stratified for CLI A- patients versus healthy controls and CLI A- patients versus CLI A+ patients. MFI median fluorescence intensity, * p<0.05.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4492682&req=5

pone.0131356.g001: Baseline platelet activation of CLI A- patients versus healthy controls and CLI A- patients versus CLI A+ patients.MFI for bound fibrinogen or P-selectin expression without stimulation, stratified for CLI A- patients versus healthy controls and CLI A- patients versus CLI A+ patients. MFI median fluorescence intensity, * p<0.05.
Mentions: Baseline platelet activation was determined with the P-selectin expression and the fibrinogen binding capacity of the patient-derived platelets without stimulation with an agonist. Baseline platelet αIIBβ3 activation did not differ between CLI A- patients and healthy controls (73.7±12.9 vs. 80.3±9.7, p = 0.682). Baseline P-selectin expression was significantly higher in CLI patients compared to healthy controls (59.4±4.8 vs. 40.3±8.6, p<0.001; Fig 1 and Fig A in S1 file).

Bottom Line: Patients with critical limb ischemia (CLI) have a high risk to develop cardiovascular events (CVE).Maximal reactivity to stimulation of the collagen and thrombin activation pathway was decreased in CLI patients compared to healthy controls.In line, attenuated platelet reactivity to stimulation of multiple activation pathways was associated with several traditional risk factors for cardiovascular disease.

View Article: PubMed Central - PubMed

Affiliation: Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, 3584CX, The Netherlands; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, 3584CX, The Netherlands.

ABSTRACT

Background: Patients with critical limb ischemia (CLI) have a high risk to develop cardiovascular events (CVE). We hypothesized that in CLI patients platelets would display increased baseline activation and reactivity.

Objectives: We investigated baseline platelet activation and platelet reactivity in patients with CLI.

Patients/methods: In this study baseline platelet activation and platelet reactivity in response to stimulation of all major platelet activation pathways were determined in 20 CLI patients (11 using aspirin and 9 using vitamin K-antagonists) included in the Juventas-trial (clinicaltrials.gov NCT00371371) and in 17 healthy controls. Platelet activation was quantified with flow cytometric measurement of platelet P-selectin expression and fibrinogen binding.

Results: CLI patients not using aspirin showed higher baseline platelet activation compared to healthy controls. Maximal reactivity to stimulation of the collagen and thrombin activation pathway was decreased in CLI patients compared to healthy controls. In line, attenuated platelet reactivity to stimulation of multiple activation pathways was associated with several traditional risk factors for cardiovascular disease.

Conclusions: Baseline platelet activation was increased in CLI patients, whereas the reactivity of circulating platelets to several stimulatory agents is decreased. Reactivity of platelets was inversely correlated with cardiovascular risk factors.

No MeSH data available.


Related in: MedlinePlus